Abdul Kadir Noor Atiqah Aizan, Rahmat Asmah, Jaafar Hawa Z E
Department of Nutrition and Dietetics, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43400 Serdang, Selangor, Malaysia.
Department of Crop Science, Faculty of Agriculture, University Putra Malaysia, 43400 Serdang, Selangor, Malaysia.
J Obes. 2015;2015:846041. doi: 10.1155/2015/846041. Epub 2015 Jun 11.
This study aims to investigate the protective effect of Cyphomandra betacea in adult male Sprague-Dawley rats fed with high fat diet. Rats were fed on either normal chow or high fat diet for 10 weeks for obesity induction phase and subsequently received C. betacea extract at low dose (150 mg kg(-1)), medium dose (200 mg kg(-1)), or high dose (300 mg kg(-1)) or placebo via oral gavages for another 7 weeks for treatment phase. Treatment of obese rats with C. betacea extracts led to a significant decrease in total cholesterol and significant increase in HDL-C (p < 0.05). Also there was a trend of positive reduction in blood glucose, triglyceride, and LDL-C with positive reduction of body weight detected in medium and high dosage of C. betacea extract. Interestingly, C. betacea treated rats showed positive improvement of superoxide dismutase (SOD) activity and glutathione peroxidase (GPx) activity along with a significant increase of total antioxidant status (TAS) (p < 0.05). Further, rats treated with C. betacea show significantly lower in TNF-α and IL-6 activities (p < 0.05). This study demonstrates the potential use of Cyphomandra betacea extract for weight maintenance and complimentary therapy to suppress some obesity complication signs.
本研究旨在探讨番茄薯在高脂饮食喂养的成年雄性斯普拉格-道利大鼠中的保护作用。在肥胖诱导阶段,大鼠分别喂食普通饲料或高脂饲料10周,随后在治疗阶段通过口服灌胃给予低剂量(150 mg kg⁻¹)、中剂量(200 mg kg⁻¹)或高剂量(300 mg kg⁻¹)的番茄薯提取物或安慰剂,持续7周。用番茄薯提取物治疗肥胖大鼠可导致总胆固醇显著降低,高密度脂蛋白胆固醇显著升高(p < 0.05)。此外,在中高剂量的番茄薯提取物中,血糖、甘油三酯和低密度脂蛋白胆固醇有降低趋势,体重也有下降。有趣的是,用番茄薯治疗的大鼠超氧化物歧化酶(SOD)活性和谷胱甘肽过氧化物酶(GPx)活性有积极改善,总抗氧化状态(TAS)显著增加(p < 0.05)。此外,用番茄薯治疗的大鼠肿瘤坏死因子-α(TNF-α)和白细胞介素-6(IL-6)活性显著降低(p < 0.05)。本研究证明了番茄薯提取物在维持体重和辅助治疗以抑制一些肥胖并发症体征方面的潜在用途。